Ikarian Capital, LLC Xenon Pharmaceuticals Inc. Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

A detailed history of Ikarian Capital, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 107,187 shares of XENE stock, worth $4.17 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
107,187
Previous 107,187 -0.0%
Holding current value
$4.17 Million
Previous $4.18 Million 0.91%
% of portfolio
0.74%
Previous 1.69%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$42.66 - $50.04 $4.57 Million - $5.36 Million
107,187 New
107,187 $4.61 Million
Q2 2023

Aug 14, 2023
SELL
$34.84 - $43.54 $871,000 - $1.09 Million
-25,000 Reduced 15.58%
135,486 $5.22 Million
Q3 2022

Nov 14, 2022
SELL
$30.79 - $39.82 $2.43 Million - $3.14 Million
-78,955 Reduced 32.97%
160,486 $5.79 Million
Q1 2022

May 13, 2022
BUY
$25.09 - $33.13 $1.51 Million - $2 Million
60,303 Added 33.66%
239,441 $7.32 Million
Q4 2021

Feb 14, 2022
SELL
$15.6 - $35.4 $3.09 Million - $7.02 Million
-198,300 Reduced 52.54%
179,138 $5.6 Million
Q3 2021

Nov 15, 2021
SELL
$14.86 - $19.45 $3.91 Million - $5.12 Million
-263,168 Reduced 41.08%
377,438 $5.77 Million
Q2 2021

Aug 16, 2021
BUY
$16.81 - $20.0 $504 - $600
30 Added 0.0%
640,606 $11.9 Million
Q1 2021

May 17, 2021
BUY
$13.65 - $21.31 $5.7 Million - $8.89 Million
417,403 Added 187.03%
640,576 $11.5 Million
Q3 2020

Nov 16, 2020
SELL
$10.82 - $13.35 $811,500 - $1 Million
-75,000 Reduced 25.15%
223,173 $2.47 Million
Q2 2020

Aug 14, 2020
SELL
$10.21 - $14.9 $1.48 Million - $2.17 Million
-145,409 Reduced 32.78%
298,173 $3.74 Million
Q1 2020

May 15, 2020
BUY
$8.08 - $17.57 $1.62 Million - $3.52 Million
200,112 Added 82.19%
443,582 $5.03 Million
Q4 2019

Jan 31, 2020
BUY
$8.11 - $14.65 $1.97 Million - $3.57 Million
243,470 New
243,470 $3.19 Million

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email